3-hydroxyflavone has been researched along with ST Elevation Myocardial Infarction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Omary, M; Boyle, AJ; Collins, N; Dib, N; Kovacs, R; McLachlan, G; Moir, S; Schultz, C; Selvanayagam, JB; Selvarajah, A; Sugito, S; Zlotnick, D | 1 |
1 trial(s) available for 3-hydroxyflavone and ST Elevation Myocardial Infarction
| Article | Year |
|---|---|
Calcium/Calmodulin-Dependent Protein Kinase II Delta Inhibition and Ventricular Remodeling After Myocardial Infarction: A Randomized Clinical Trial.
Topics: Aged; Aged, 80 and over; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Double-Blind Method; Female; Flavonols; Humans; Male; Middle Aged; ST Elevation Myocardial Infarction; Ventricular Dysfunction, Left; Ventricular Remodeling | 2021 |